Crowell Systems' Medformix XXV v3 earns Ambulatory Software Certification

NewsGuard 100/100 Score

Crowell Systems, Inc.'s Medformix XXV v3 received the Federal Government's "meaningful use" stamp of approval on March 8, 2011 by earning Ambulatory Software Certification. The designation officially deems the electronic health record (EHR) software capable of enabling providers to qualify for funding under the American Recovery and Reinvestment Act (ARRA). Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, Medformix XXV v3 is 2011/2012 compliant in accordance with the criteria adopted by the Secretary of Health and Human Services.  

"Healthcare providers can now leverage our software to not only make significant care improvements but to also achieve meaningful use and qualify for incentive funds under ARRA. We believe this certification demonstrates Crowell's commitment to supporting our clients. We are proud to offer providers the opportunity to truly improve care in their communities," states Sally Crowell, President of Crowell Systems.

Medformix XXV v3 is a very powerful, all-encompassing software solution which includes Practice Management functionality and a robust EHR. The flexible chart can be customized to fit any doctor's requirements. Chartscore® automatically grades EMR for correct CPT coding. This feature enables the doctors to charge accurately for each visit.

Source:

Crowell Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions